Associate Chief, Hematology, Director Blood and Marrow Transplant and Cell Therapy
UCSF
San Francisco, California, United States
Dr Martin is a Clinical Professor of Medicine and Associate Chief the Division of Hematology/Oncology, Director of the Hematologic Malignancies Research Site Committee, Co-Director of the Myeloma Program and Co-Lead for the Hematologic Malignancies Research Program in the Helen Dillier Family Comprehensive Cancer Center at the University of California, San Francisco. Dr Martin has authored many artciles in hematologic malignancies and has been a thought leader and an invited speaker at national and international meetings. He been actively involved in clinical research and has been principal investigator (PI) on over 25 clinical trials. Dr Martin has supervised the multiple myeloma (MM) tissue bank at UCSF since it’s inception in 2009, and this biobank has been utilized for biomarker discovery.
Dr Martin’s main research interests are the development and evaluation of novel therapeutics for multiple myeloma. He has been involved in the clinical development of the novel anti-CD38 monoclonal antibody, isatuximab and lead the studies testing the combination of isatuximab, carfilzomib and dexamethasone. Dr. Martin is involved in many other immunotherapy trials including antibody-drug conjugate, chimeric antigen receptor (CAR) T, and bispecific T-cell redirection antibody trials. Dr Martin is the PI of the first UCSF manufactured novel BCMA targeted CAR-T therapy trial in relapsed MM.
Friday, September 29, 2023
11:15 AM – 11:45 AM EEST
Friday, September 29, 2023
3:05 PM – 3:10 PM EEST